Cleneay Inc Headquarters

Looking for information about Cleneay Inc Headquarters? The links below have collected all the necessary data.

Cleneay Inc 13918 Saint Marys Ln, Houston, TX 77079 - …

https://www.yellowpages.com/houston-tx/mip/cleneay-inc-458617889

Get reviews, hours, directions, coupons and more for Cleneay Inc at 13918 Saint Marys Ln, Houston, TX 77079. Search for other Oil & Gas Exploration & Development in Houston on The Real Yellow Pages®.Location: 13918 Saint Marys Ln, Houston, 77079, TX

Cleneay, Inc. in Houston, TX Company Information & Reviews

https://www.bizapedia.com/tx/cleneay-inc.html

Cleneay, Inc. is a Texas Domestic For-Profit Corporation filed On July 19, 1999. The company's filing status is listed as Voluntarily Dissolved and its File Number is 0154293000. The Registered Agent on file for this company is Charles A Cleneay and is located at …Location: TX

1944 Cleneay, Ltd. in Cincinnati, OH Company Info & Reviews

https://www.bizapedia.com/oh/1944-cleneay-ltd.html

1944 Cleneay, Ltd. is an Ohio Domestic Limited-Liability Company filed On May 23, 2001. The company's filing status is listed as Active and its File Number is 1233370. The Registered Agent on file for this company is J. David Argus and is located at 3582 Outlook Avenue, Cincinnati, OH 45208.Founded: May 23, 2001

Contact Us - Clearway Energy Group

https://www.clearwayenergygroup.com/contact-us/

We would like to hear from you – whether you are interested in partnering with us, buying power from one of our wind or solar projects, applying for a role within our company, or just want to learn more about Clearway in general.

Cleanway Maintenance, Inc. LinkedIn

https://www.linkedin.com/company/cleanway-maintenance-inc-

Cleanway Maintenance, Inc. has been committed to providing commercial institutions in the great Chicago area with superior janitorial services for 25 years. Unlike large corporate companies who ...Founded: 1996

Clene Inc. Nanomedicine in Pharmaceutical Research

https://clene.com/

Clene has a new vision for a pharmaceutical future using therapeutic nanocatalysts to improve cellular bioenergetics. Clene’s clinical program targets neurodegenerative disease to improve cellular bioenergetic function with nanocatalysts. Current Phase 2 studies include treatment of multiple sclerosis, Parkinson’s disease, and amyotrophic ...